DRKS00010788Recruiting未知
Pilot Study on Effects of the Dialysis Mode on Posttranslational Modifications of Proteins - Dialysis and protein modifications
Dialysezentrum Elsenfeld0 sites15 target enrollmentStarted: July 4, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 15
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized controlled study
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Age = 18 years
- •End-stage renal failure
- •Chronic hemodialysis or hemodiafiltration treatment for more than three months
- •Hematocrit above 30 %
- •Stable anticoagulation and erythropoietin regimen
- •No vascular access related problems (A/V-fistula or bi-flow catheter)
- •No ongoing infection
- •Signed informed consent form
Exclusion Criteria
- •Inclusion criteria not met
- •Known HIV or hepatitis B or C infection.
- •Unstable clinical condition (e.g. cardiac or vascular instability)
- •Life expectancy less than 12 months
- •Known coagulation problems
- •Patients participating in another study interfering with the planned trial
Investigators
Similar Trials
Completed
Not Applicable
A retrospective study on perioperative dialysis of TAVI and AVR in patients receiving maintenance hemodialysis with severe aortic valve stenosis.Aortic valve stenosis. End-stage kidney disease.JPRN-UMIN000046157Department of Nephrology, Endocrinology and Diabetes, Tokyo Bay Urayasu Ichikawa Medical Center50
Completed
Not Applicable
The Effects of Dialysis dose at the Initiation of Treatment on Peritoneal DialysisJPRN-UMIN000018433Department of Internal Medicine, St. Marianna University School of Medicine, Division of Nephrology and Hypertension80
Not yet recruiting
Phase 3
Effects of Dialysate/Replacement Supraphysiologic Sodium Concentration and Hemodynamic Stability in Critically-ill Patients receiving Continuous Renal Replacement Therapy (CRRT) : A Randomized, Double-blinded, Controlled StudyCritically-ill patients requiring continuous renal replacement therapyContinuous renal replacement therapyContinuous venovenous hemofiltrationContinuous venovenous hemodiafiltrationReplacement fluidDialysis fluidTCTR20200108001Division of Nephrology, Department of Internal Medicine, Faculty of Medicine64
Unknown
Phase 3
Clinical Study in Peritoneal Dialysis PatientsChronic Kidney DiseaseJPRN-jRCT2080221395JAPAN TABACCO INC.50
Completed
Not Applicable
Clinical effects of a peritoneal dialysis fluid with neutral PH , using Automated peritoneal dialysis patientsJPRN-UMIN000019741Tokai University Hachioji Hospital30